SNMMI highlights gallium-68 shortage in letter to FDA

​

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has written a letter to the FDA about ongoing shortages of generators that produce gallium-68 (Ga-68), a radioisotope used regularly in medical imaging.

In the letter, the SNMMI noted that the use of Ga-68 has increased in the U.S. since the 2016 approval of Ga-68 DOTATATE (Netspot, Advanced Accelerator Applications [AAA]) for PET scans to localize NETs in adult and pediatric patients.

The letter—available here—is signed by Cathy S. Cutler, PhD, chair of the SNMMI Committee on Radiopharmaceuticals, and SNMMI President Satoshi Minoshima, MD, PhD.

To read more please visit: https://www.radiologybusiness.com/topics/policy/snmmi-fda-gallium-68-pet

Source: Radiology Business